Kuba, Sayaka <br/><br/>
Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer.  [electronic resource] 

 -  Breast cancer (Tokyo, Japan)  Jan 2016 
 - 128-133 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1880-4233 
<br/><br/><label>Standard No.: </label>10.1007/s12282-014-0540-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Aromatase Inhibitors--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Chemotherapy, Adjuvant--statistics & numerical data<br/>Cohort Studies<br/>Drug Costs<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Japan<br/>Lymph Nodes--pathology<br/>Mastectomy<br/>Middle Aged<br/>Neoplasm Staging<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Retrospective Studies<br/>Selective Estrogen Receptor Modulators--therapeutic use<br/>Young Adult<br/>Assessment of Medication Adherence